Retinal nerve fiber layer as measured by optical coherence tomography may act as a surrogate measure for neuroaxonal loss in patients with multiple sclerosis.“There is a strong association between measures of retinal neuroaxonal loss and brain atrophy …
Month: September 2021
No predictive risk factors identified for endophthalmitis following pars plana vitrectomy
Researchers were unable to identify any predictive risk factors for endophthalmitis following pars plana vitrectomy, according to a poster presentation at the Women in Ophthalmology Summer Symposium.Alexa R. Thibodeau, MD, and colleagues, conducted a r…
Surgical procedure shows long-term efficacy in the treatment of neurotrophic keratopathy
Corneal neurotization, a sensory nerve transplant procedure, can restore corneal sensation in insensate corneas and improve visual acuity.Cat N. Burkat, MD, and Andrea L. Kossler, MD, presented and discussed the results of this technique at the Women i…
Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
Split-face study finds no difference between neurotoxins for glabellar lines
A split-face comparison found no difference between onabotulinumtoxinA and prabotulinumtoxinA for the treatment of glabellar frown lines, according to a study presented at the Women in Ophthalmology Summer Symposium.“We sought to evaluate the differenc…
Cleveland Clinic’s New Prosthetic Arm with Advanced Functionality
Researchers at the Cleveland Clinic have developed an advanced bionic arm that allows users with upper limb amputations to achieve a similar level of function as non-amputees. The system incorporates a sense of touch and movement and allows for intuitive motor control. The device is intended for users who have undergone targeted sensory and motor […]
2021 Report Leber Congenital Amaurosis Drugs In Development – Featuring Atsena Therapeutics, Editas Medicine and Generation Bio Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Leber Congenital Amaurosis (LCA) (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Leber Congenital Amaurosis (Genetic Disorde…
With resurgence of LASIK, debate reemerges on femto vs. mechanical microkeratomes
If people with vision correction needs learned one thing during the COVID-19 pandemic, it was that masks and glasses do not mix.However, foggy glasses are just one factor that has contributed to an uptick in LASIK and other laser vision correction proc…
What LASIK flap maker do you use, and why?
Click here to read the Cover Story, “With resurgence of LASIK, debate reemerges on femto vs. mechanical microkeratomes.”I use the Ziemer CrystalLine femtosecond laser system to make my LASIK flaps because I think femto is the safest and most effective …
Surgeon shares experience with Preserflo microshunt
In the last 50 years, trabeculectomy with antimetabolites has been the gold standard of glaucoma surgical treatment, with valved or non-valved glaucoma drainage devices also in use.Both techniques have significant complications and are burdensome for t…
Screening needed for pentosan polysulfate sodium-associated maculopathy
Interstitial cystitis, also known as bladder pain syndrome, can be incapacitating for patients, keeping them up at night with constant feelings of urinary urgency.Currently, the only approved medication for the condition is Elmiron (pentosan polysulfat…
Refractive corneal surgery poised for strong comeback in 2021
The top five procedures performed by United States ophthalmologists are:Most of the intravitreal injections are performed by approximately 2,000 fellowship-trained retina/vitreous specialists. The growth in this office-based procedure has made retina t…
Man presents with visual field changes over 1 year
A 66-year-old man was seen in the glaucoma clinic at Tufts Medical Center due to visual field changes, referred to neurology and then to neuro-ophthalmology with gradual left-sided peripheral visual field haziness over the past year.He had no history o…
Let it rain: Premium surgeons can remain confident
One of my favorite phrases of all time is “let it rain,” a proclamation of confidence when the “win” is imminent regardless of the trials that may be faced along the way.Premium surgeons must always convey a ray of confidence, whether it be in the exam…
Cell therapy approaches goal of restoring vision in geographic atrophy
A cell replacement therapy that uses retinal pigment epithelium-derived stem cells is showing the potential to restore retinal tissue in advanced age-related macular degeneration with geographic atrophy.“When we designed the trial, our aim was to stop …
Are you an associate ophthalmologist?
“It might be said that it is the ideal of the employer to have production without employees and the ideal of the employee is to have income without work.” – E. F. SchumacherAspiring to and then becoming an equal partner in a private practice has been t…
Advanced Vision Analyzer: Is virtual reality perimetry the next big thing?
Amar Agarwal, MS, FRCS, FRCOphth, is a master surgeon, prolific writer and superb educator. He just submitted his 200th column to OSN on ocular surgery complication management. I want to personally thank him for this exceptional achievement.Richard L. …
Newer and some longer-term use medications linked to acute retinal toxicity
Some newly approved, as well as several long-term use medications, have been recently associated with acute retinal toxicity, according to a poster presentation at the Women in Ophthalmology Summer Symposium.”This review highlights the most recent upda…
Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic-focused healthcare company, and Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing first-in-class medicines for sedation and anal…
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to three newly-hired, non-executive employees.